Point72 Asset Management L.P. purchased a new stake in ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 218,803 shares of the company's stock, valued at approximately $3,993,000. Point72 Asset Management L.P. owned 0.80% of ZimVie as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of ZIMV. Dimensional Fund Advisors LP raised its holdings in ZimVie by 3.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,035,069 shares of the company's stock valued at $18,889,000 after acquiring an additional 36,846 shares during the period. American Century Companies Inc. grew its position in shares of ZimVie by 212.8% in the second quarter. American Century Companies Inc. now owns 412,434 shares of the company's stock valued at $7,527,000 after purchasing an additional 280,565 shares in the last quarter. Renaissance Technologies LLC grew its position in shares of ZimVie by 26.6% in the second quarter. Renaissance Technologies LLC now owns 406,400 shares of the company's stock valued at $7,417,000 after purchasing an additional 85,300 shares in the last quarter. Gamco Investors INC. ET AL raised its stake in shares of ZimVie by 6.0% during the 1st quarter. Gamco Investors INC. ET AL now owns 343,717 shares of the company's stock valued at $5,668,000 after purchasing an additional 19,459 shares during the period. Finally, Russell Investments Group Ltd. lifted its holdings in ZimVie by 0.7% during the 1st quarter. Russell Investments Group Ltd. now owns 281,377 shares of the company's stock worth $4,640,000 after purchasing an additional 1,964 shares in the last quarter. 95.63% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other ZimVie news, major shareholder Camber Capital Management Lp sold 525,000 shares of ZimVie stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the completion of the sale, the insider now directly owns 2,725,000 shares in the company, valued at $48,259,750. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 3.01% of the stock is owned by company insiders.
ZimVie Price Performance
NASDAQ:ZIMV traded down $0.14 during trading hours on Thursday, hitting $15.65. The stock had a trading volume of 82,078 shares, compared to its average volume of 337,348. The company has a 50 day simple moving average of $17.35 and a two-hundred day simple moving average of $17.10. The firm has a market capitalization of $431.47 million, a price-to-earnings ratio of -1.12 and a beta of 2.13. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.94 and a quick ratio of 1.43. ZimVie Inc. has a one year low of $6.52 and a one year high of $22.40.
ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its earnings results on Thursday, August 1st. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.04). The business had revenue of $116.81 million for the quarter. ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. During the same period last year, the firm posted $0.17 EPS. Research analysts forecast that ZimVie Inc. will post 0.63 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Separately, Needham & Company LLC lifted their target price on ZimVie from $20.00 to $23.00 and gave the company a "buy" rating in a report on Friday, August 2nd.
Get Our Latest Analysis on ZimVie
About ZimVie
(
Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Further Reading
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
